No detectable analgesic effects in the formalin test even with one million bovine adrenal chromaffin cells

Pain

Volumn 99, Issue 1-2, 2002, Pages 263-271

  Gulwadi, Amit G ^a   Hoane, Michael R ^a   Saydoff, Joel A ^a   Frydel, Beata R ^a   Lindner, Mark D ^a,b  

^a CytoTherapeutics Inc   (United States)

^b NONE   (United States)

Author keywords

Analgesic agents; Bovine adrenal chromaffin cells; Nicotine stimulation

Indexed keywords

ANALGESIC AGENT; FORMALDEHYDE; NICOTINE;

ANALGESIC ACTIVITY; ANIMAL CELL; ARTICLE; CATTLE; CELL COUNT; CELL IMMORTALIZATION; CELL LINE; CELL TRANSPLANTATION; CHROMAFFIN CELL; CONTROLLED STUDY; LITERATURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; CATTLE; CELL COUNT; CHROMAFFIN CELLS; INJECTIONS, SPINAL; MALE; NICOTINE; NICOTINIC AGONISTS; NOREPINEPHRINE; OPIOID PEPTIDES; PAIN MEASUREMENT; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; STIMULATION, CHEMICAL;

EID: 0036711242     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00120-3     Document Type: Article

References (61)

1. Aebischer P., Buchser E., Joseph J.M., Favre J., De Tribolet N., Lysaght M., Rudnick S., Goddard M. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression: a preliminary report. Transplantation. 58:1994;1275-1277.
2. Bartfai T., Hokfelt T., Langel U. Galanin - a neuroendocrine peptide. Crit Rev Neurobiol. 7:1993;229-274.
3. Bes J.C., Tkaczuk J., Czech K.A., Tafani M., Bastide R., Caratero C., Pappas G.D., Lazorthes Y. One-year chromaffin cell allograft survival in cancer patients with chronic pain: morphological and functional evidence. Cell Transplant. 7:1998;227-238.
4. Brown S.T., Edwards F.F., Bernard E.M., Niki Y., Armstrong D. Progressive disseminated infection with Mycobacterium avium complex after intravenous and oral challenge in cyclosporine-treated rats. J Infect Dis. 164:1991;922-927.
5. Buchser E., Goddard M., Heyd B., Joseph J.M., Favre J., deTribolet N., Lysaght M., Aebischer P. Immunoisolated xenogeneic chromaffin cell therapy for chronic pain: initial clinical experience. Anesthesiology. 85:1996;1005-1012.
6. Crisp T., Stafinsky J.L., Hess J.E., Uram M. Spinal beta-endorphin analgesia involves an interaction with local monoaminergic systems. Eur J Pharmacol. 160:1989;211-217.
7. Cui J.G., Linderoth B., Meyerson B.A. Effects of spinal cord stimulation on touch-evoked allodynia involve GABAergic mechanisms. An experimental study in the mononeuropathic rat. Pain. 66:1996;287-295.
8. Czech K.A., Sagen J. Update on cellular transplantation into the CNS as a novel therapy for chronic pain. Prog Neurobiol. 46:1995;507-529.
9. Decosterd I., Buchser E., Gilliard N., Saydoff J., Zurn A., Aebischer P. Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain. Pain. 76:1998;159-166.
10. Eiden L.E., Giraud P., Dave J.R., Hotchkiss A.J., Affolter H.U. Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells. Nature. 312:1984;661-663.
11. Fisone G., Langel U., Carlquist M., Bergman T., Consolo S., Hokfelt T., Unden A., Andell S., Bartfai T. Galanin receptor and its ligands in the rat hippocampus. Eur J Biochem. 181:1989;269-276.
12. Hama A.T., Sagen J. Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy. Pain. 52:1993;223-231.
13. Hama A.T., Sagen J. Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space. Brain Res. 651:1994;183-193.
14. Hama A.T., Unnerstall J.R., Siegan J.B., Sagen J. Modulation of NMDA receptor expression in the rat spinal cord by peripheral nerve injury and adrenal medullary grafting. Brain Res. 687:1995;103-113.
15. Hentall I.D., Sagen J. The alleviation of pain by cell transplantation. Prog Brain Res. 127:2000;535-550.
16. Kuraishi Y., Hirota N., Satoh M., Takagi H. Antinociceptive effects of intrathecal opioids noradrenaline and serotonin in rats: mechanical and thermal algesic tests. Brain Res. 326:1985;168-171.
17. Lazorthes Y., Bes J.C., Sagen J., Tafani M., Tkaczuk J., Sallerin B., Nahri I., Verdie J.C., Ohayon E., Caratero C., Pappas G.D. Transplantation of human chromaffin cells for control of intractable cancer pain. Meyerson B.A., Ostertag C., Advances in stereotactic and functional neurosurgery 11. 1995;97-100 Springer, Berlin.
18. Lazorthes Y., Sagen J., Sallerin B., Tkaczuk J., Duplan H., Sol J., Tafani M., Bes J. Human chromaffin cell graft into the CSF for cancer pain management: a prospective phase II clinical study. Pain. 87:2000;19-32.
19. Lemaire S., Shukla V.K., Rogers C., Ibrahim I.H., Lapierre C., Parent P., Dumont M. Isolation and characterization of histogranin, a natural peptide with NMDA receptor antagonist activity. Eur J Pharmacol. 245:1993;247-256.
20. Lindner M.D., Francis J.M., McDermott P.E., Bell W.J., Blaney T.J., Sherman S.S., Saydoff J.A. Numerous adrenal chromaffin cell preparations fail to produce analgesic effects in the formalin test or in tests of acute pain even with nicotine stimulation. Pain. 88:2000;177-188.
21. Lindner M.D., Francis J.M., Plone M.A., McDermott P.E., Frydel B.R., Emerich D.F., Saydoff J.A. The analgesic potential of intraventricular polymer-encapsulated adrenal chromaffin cells in a rodent model of chronic neuropathic pain. Exp Clin Psychopharmacol. 8:2000;524-538.
22. Lindner M.D., Francis J.M., Saydoff J.A. Intrathecal polymer-encapsulated bovine adrenal chromaffin cells fail to produce analgesic effects in the hotplate and formalin test. Exp Neurol. 165:2000;370-383.
23. Lindner M.D., Frydel B., Kaplan F.A., Krueger P.M., Bell W.J., Blaney T.J., Winn S.R., Sherman S.S., Doherty E.J., Emerich D.F. Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats. Restor Neurol Neurosci. 11:1997;21-35.
24. Michalewicz P., Laurito C.E., Pappas G.D., Lu Y., Yeomans D.C. Purification of adrenal chromaffin cells increases antinociceptive efficacy of xenotransplants without immunosuppression. Cell Transplant. 8:1999;103-109.
25. Ortega-Alvaro A., Gibertrahola J., Chover A.J., Tejedor-Real P., Casas J., Mico J.A. Effect of amitriptyline on the analgesia induced by adrenal medullary tissue transplanted in the rat spinal subarachnoid space as measured by an experimental model of acute pain. Exp Neurol. 130:1994;9-14.
26. Ortega-Alvaro A., Gibertrahola J., Mellado-Fernandez M.L., Chover A.J., Mico J.A. The effects of different monoaminergic antidepressants on the analgesia induced by spinal cord adrenal medullary transplants in the formalin test in rats. Anesth Analg. 84:(4):1997;816-820.
27. Pappas G.D., Lazorthes Y., Bes J.C., Tafani M., Winnie A.P. Relief of intractable cancer pain by human chromaffin cell transplants: experience at two medical centers. Neurol Res. 19:1997;71-77.
28. Pappas G.D., Sagen J. Morphological correlates of chromaffin cell transplants in CNS pain modulatory regions. Tissue engineering. 1988;283-288 Alan R. Liss, Inc, New York, NY.
29. Rosenthal R. Experimenter effects in behavioral research. 1966;Appleton Century Crofts (Division of Meredith Publishing Co), New York, NY.
30. Sagen J. Chromaffin cell transplants for alleviation of chronic pain. ASAIO J. 38:1992;24-28.
31. Sagen J. Chromaffin cell transplants in the CNS: basic and clinical update. Lanza R.P., Chick W.L., Yearbook of cell and tissue transplantation. 1997;71-89 Kluwer Academic, Dordrecht.
32. Sagen J., Kemmler J.E. Increased levels of Met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants. Brain Res. 502:1989;1-10.
33. Sagen J., Kemmler J.E., Wang H. Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity. J Neurochem. 56:1991;623-627.
34. Sagen J., Ortega J.D., Pappas G.D. Neuropeptide and catecholamine delivery to central nervous system by implanted chromaffin cells. Methods Neurosci. 21:1994;348-368.
35. Sagen J., Pappas G.D. Morphological and functional correlates of chromaffin cell transplants in CNS pain modulatory regions. Ann NY Acad Sci. 495:1987;306-333.
36. Sagen J., Pappas G.D. Pain reduction by chromaffin cell grafts in the CNS. Tissue engineering. 1988;289-294 Alan R. Liss, Inc, New York, NY.
37. Sagen J., Pappas G.D., Perlow M.J. Adrenal medullary tissue transplants in the rat spinal cord reduce pain sensitivity. Brain Res. 384:1986;189-194.
38. Sagen J., Pappas G.D., Pollard H.B. Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. Proc Natl Acad Sci USA. 83:1986;7522-7526.
39. Sagen J., Pappas G.D., Perlow M.J. Alterations in nociception following adrenal medullary transplants into the rat periaqueductal gray. Exp Brain Res. 67:1987;373-379.
40. Sagen J., Wang H. Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants. Eur J Pharmacol. 179:1990;427-433.
41. Sagen J., Wang H., Pappas G.D. Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model. Pain. 42:1990;69-79.
42. Sagen J., Wang H., Tresco P.A., Aebischer P. Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J Neurosci. 13:1993;2415-2423.
43. Shukla V.K., Lemaire S., Dumont M., Merali Z. N-methyl-D-aspartate receptor antagonist activity and phencyclidine-like behavioral effects of the pentadecapeptide, [Ser1]histogranin. Pharmacol Biochem Behav. 50:1995;49-54.
44. Siegan J.B., Hama A.T., Sagen J. Suppression of neuropathic pain by a naturally-derived peptide with NMDA antagonist activity. Brain Res. 755:1997;331-334.
45. Siegan J.B., Sagen J. Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants. Brain Res. 680:1995;88-98.
46. Siegan J.B., Sagen J. A natural peptide with NMDA inhibitory activity reduces tonic pain in the formalin model. NeuroReport. 8:1997;1379-1381.
47. Siegan J.B., Sagen J. Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space. Pain. 70:1997;279-285.
48. Stine S.M., Yang H.Y., Costa E. Release of enkephalin-like immunoreactive material from isolated bovine chromaffin cells. Neuropharmacology. 19:1980;683-685.
49. Tan L., Yu P.H. Biosynthesis of enkephalins by chromaffin cells of bovine adrenal medulla. Biochem Biophys Res Commun. 95:1980;1901-1908.
50. Tan S.A., Aebischer P. The problems of delivering neuroactive molecules to the CNS. Bock G.R., Goode J.A., Growth factors as drugs for neurological and sensory disorders. 1996;211-236 Wiley, Chichester.
51. Terenghi G., Polak J.M., Varndell I.M., Lee Y.C., Wharton J., Bloom S.R. Neurotensin-like immunoreactivity in a subpopulation of noradrenaline-containing cells of the cat adrenal gland. Endocrinology. 112:1983;226-233.
52. Vaquero J., Arias A., Oya S., Zurita M. Chromaffin allografts into arachnoid of spinal cord reduce basal pain responses in rats. NeuroReport. 2:1991;149-151.
53. Wang H., Sagen J. Optimization of adrenal medullary allograft conditions for pain alleviation. J Neural Transplant Plast. 5:1994;49-64.
54. Wang H., Sagen J. Attenuation of pain-related hyperventilation in adjuvant arthritis rats with adrenal medullary transplants in the spinal subarachnoid space. Pain. 63:1995;313-320.
55. Wiesenfeld-Hallin Z., Xu X.J., Villar M.J., Hokfelt T. The effect of intrathecal galanin on the flexor reflex in rat: increased depression after sciatic nerve section. Neurosci Lett. 105:1989;149-154.
56. Wilson S.P., Kwen-Jen C., Viveros O.H. Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture. J Neurosci. 2:1982;1150-1156.
57. Winnie A.P., Pappas G.D., Gupta T.K., Wang H., Ortega J.D., Sagen J. Subarachnoid adrenal medullary transplants for terminal cancer pain: a report of preliminary studies. Anesthesiology. 79:1993;644-653.
58. Yadid G., Zangen A., Herzberg U., Nakash R., Sagen J. Alterations in endogenous brain beta-endorphin release by adrenal medullary transplants in the spinal cord. Neuropsychopharmacology. 23:2000;709-716.
59. Yu W., Hao J.X., Xu X.J., Saydoff J., Haegerstrand A., Hokfelt T., Wiesenfeldhallin Z. Long-term alleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury. Pain. 74:1998;115-122.
60. Yu W., Haoa J.X., Xu X.J., Saydoff J., Sherman S., Eriksson A., Haegerstrand A., Wiesenfeld-Hallin Z. Immunoisolating encapsulation of intrathecally implanted bovine chromaffin cells prolongs their survival and produces anti-allodynic effect in spinally injured rats. Eur J Pain. 2:1998;143-151.
61. Zimmermann M. Ethical guidelines for investigators of experimental pain in conscious animals. Pain. 16:1983;109-110.